RenovoRx (RNXT) CFO granted 12,380 RSUs, now reports 134,580 shares

Rhea-AI Filing Summary

VOLL MARK reported acquisition or exercise transactions in this Form 4 filing.

RenovoRx, Inc. chief financial officer Mark Voll reported an equity grant of 12,380 shares of common stock. These shares were granted as restricted stock units for his service as a consultant of the company for January 2026 and carry a stated price of $0.00 per share.

Following this grant, Voll directly holds 37,380 shares of common stock and has an additional 97,200 shares reported as indirectly held through the Voll Family Trust DTD 6/23/2010, with Mark Voll as trustee. This filing reflects compensation rather than an open-market stock purchase.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider VOLL MARK

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,380	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 37,380 shares (Direct); Common Stock — 97,200 shares (Indirect, Voll Family Trust DTD 6/23/2010 Mark Voll TTEE)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VOLL MARK

(Last) (First) (Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 320

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026	03/25/2026	A		12,380(1)	A	$0(1)	37,380	D
Common Stock								97,200	I	Voll Family Trust DTD 6/23/2010 Mark Voll TTEE

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction involved the Reporting Person's receipt of a grant of 12,380 restricted stock units for his service as a consultant of the Issuer for January 2026.

	/s/ Mark Voll	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did RenovoRx (RNXT) report for CFO Mark Voll?

RenovoRx reported that CFO Mark Voll received a grant of 12,380 restricted stock units of common stock as compensation for his service as a consultant for January 2026, rather than buying shares in the open market.

How many RenovoRx (RNXT) shares does Mark Voll hold after this Form 4?

After the reported grant, Mark Voll directly holds 37,380 shares of RenovoRx common stock and has 97,200 shares reported as indirectly held through the Voll Family Trust DTD 6/23/2010, where he is listed as trustee.

Was the RenovoRx (RNXT) Form 4 transaction an open-market purchase?

No. The Form 4 shows a grant of 12,380 restricted stock units at a stated price of $0.00 per share as compensation for consulting services, not an open-market stock purchase by CFO Mark Voll.

What is the nature of the 12,380-share award to RenovoRx (RNXT) CFO Mark Voll?

The 12,380 shares are reported as restricted stock units granted to Mark Voll for his service as a consultant of RenovoRx for January 2026, representing a compensation-related equity award rather than a discretionary trading transaction.

How are Mark Voll’s indirect holdings in RenovoRx (RNXT) reported?

The filing lists 97,200 RenovoRx common shares as indirectly owned by Mark Voll through the Voll Family Trust DTD 6/23/2010, with the nature of ownership described as “Mark Voll TTEE,” indicating trust-held shares associated with him.